Buparlisib is an effective second-line treatment
Crossref DOI link: https://doi.org/10.1038/nrclinonc.2017.22
Published Online: 2017-02-14
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sidaway, Peter
Text and Data Mining valid from 2017-02-14
Article History
First Online: 14 February 2017